Your critical care patient may have HLH (hemophagocytic lymphohistiocytosis)

Crit Care. 2016 Jul 6;20(1):215. doi: 10.1186/s13054-016-1369-3.

Authors

Rafal Machowicz¹, Gritta Janka², Wieslaw Wiktor-Jedrzejczak³

Affiliations

¹ Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, ul. Banacha 1a, 02-097, Warsaw, Poland. r.machowicz@wp.pl.
² Department of Paediatric Haematology and Oncology, University Medical Centre Hamburg Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
³ Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, ul. Banacha 1a, 02-097, Warsaw, Poland.

No abstract available

Publication types

Editorial

MeSH terms

Critical Illness
Diagnosis, Differential
Etoposide / pharmacology
Etoposide / therapeutic use
Humans
Intensive Care Units / organization & administration
Iron / analysis
Iron / blood
Lymphohistiocytosis, Hemophagocytic / diagnosis*
Lymphohistiocytosis, Hemophagocytic / physiopathology*
Lymphohistiocytosis, Hemophagocytic / therapy
Topoisomerase II Inhibitors / pharmacology
Topoisomerase II Inhibitors / therapeutic use

Substances

Topoisomerase II Inhibitors
Etoposide
Iron